Aptamers Market

1. Aptamers Market accounted for US$ 205.40 million in 2020 and is estimated to be US$ 985.44 million by 2030 and is anticipated to register a CAGR of 16.90%. Aptamers market is projected to grow from US$ 205.40 million in 2019 to US$ 985.44 million by 2030. Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are the major key driving factors responsible for the growth of global aptamers market. Low cost and high efficacy in binding to large molecules compared to antibodies and the patent expiration of systemic evolution of ligands by exponential enrichment technology (SELEX) which boosts the global market positively. Key Market Insights from the report: The aptamers market accounted for US$ 205.40 million in 2020 and is projected to register a moderate CAGR of 16.90%. over the forecast period. The market report has been segmented on the type, application, and region.  By region, North America is projected to lead the global aptamers market and is expected to remain dominant, due to rapid technological advancements and high investment and funding to support the development of aptamers. To know the upcoming trends and insights prevalent in this market, click the link below: https://prophecymarketinsights.com/market_insight/Global-Aptamers-Market-By-Type- 3879 The prominent player operating in the global aptamers market includes Somalogic, Inc., Noxxan Pharma AG, Aptamer Science Inc., Aptagen, Inc, AM Biotechnologies LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., TriLink BioTechnologies, Inc. Related Topics: https://www.prophecymarketinsights.com/market_insight/Global-Interventional- Cardiology-Devices-Market-721 https://www.prophecymarketinsights.com/market_insight/Global-Surgical-Sealants-and- Adhesives-Market-4401 https://www.prophecymarketinsights.com/market_insight/Global-Insulin-Delivery-Devices- Market-249